StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
LFMD

LifeMD, Inc.

LFMDP Nasdaq Services-Offices & Clinics of Doctors of Medicine EDGAR ↗
$23.46
+0.03 +0.13%

Key statistics

from XBRL data in SEC filings
Market cap
$1.13B
Revenue (TTM)
$193M
Net income (TTM)
-$19.9M
EPS (TTM)
$0.25
P/E ratio
93.8
Dividend yield
13240626.60%
Free cash flow
$6.41M
Cash
$34.5M
Total assets
$70.1M
Gross margin
86.8%
52-week range
$18.50 – $24.25

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Regulation FD disclosure Jun 22, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 6, 2026 8-K Director or officer change; Other events Mar 18, 2026 10-K Fiscal year ended 2025-12-31 Mar 10, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 9, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Jan 6, 2026 10-Q Quarter ended 2025-09-30 Nov 17, 2025 8-K Results of operations (earnings release) Nov 17, 2025 8-K Regulation FD disclosure Nov 5, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Regulation FD disclosure Nov 4, 2025 8-K Changed accountants Aug 21, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Director or officer change; Other events Jul 31, 2025 8-K Shareholder vote results Jun 16, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Regulation FD disclosure Apr 29, 2025 8-K Changed accountants Apr 25, 2025 10-K Fiscal year ended 2024-12-31 Mar 11, 2025 8-K Results of operations (earnings release) Mar 10, 2025 8-K Director or officer change Dec 31, 2024 8-K Director or officer change Dec 23, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Director or officer change Oct 31, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Director or officer change; Shareholder vote results Jun 18, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Director or officer change; Other events May 2, 2024 10-K Fiscal year ended 2023-12-31 Mar 11, 2024 8-K Unregistered sale of equity; Regulation FD disclosure; Other events Dec 13, 2023 8-K Director or officer change Nov 14, 2023 10-Q Quarter ended 2023-09-30 Nov 8, 2023 8-K Regulation FD disclosure Aug 10, 2023 10-Q Quarter ended 2023-06-30 Aug 9, 2023 8-K Director or officer change Jul 31, 2023 8-K Director or officer change Jul 14, 2023 8-K Shareholder vote results Jul 7, 2023 8-K Director or officer change; Other events Jun 22, 2023